80 related articles for article (PubMed ID: 27380317)
21. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).
Yun NE; Linde NS; Zacks MA; Barr IG; Hurt AC; Smith JN; Dziuba N; Holbrook MR; Zhang L; Kilpatrick JM; Arnold CS; Paessler S
Virology; 2008 Apr; 374(1):198-209. PubMed ID: 18234269
[TBL] [Abstract][Full Text] [Related]
22. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Sidwell RW; Barnard DL; Day CW; Smee DF; Bailey KW; Wong MH; Morrey JD; Furuta Y
Antimicrob Agents Chemother; 2007 Mar; 51(3):845-51. PubMed ID: 17194832
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus.
Qiu H; Andersen H; Tarbet EB; Muhammad FS; Carnelley T; Pronyk R; Barker D; Kodihalli S
Antiviral Res; 2020 Aug; 180():104753. PubMed ID: 32114033
[TBL] [Abstract][Full Text] [Related]
26. A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus.
Röhrs S; Kalthoff D; Beer M
Vaccine; 2014 May; 32(22):2631-6. PubMed ID: 24674664
[TBL] [Abstract][Full Text] [Related]
27. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
[TBL] [Abstract][Full Text] [Related]
28. Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
Reddy MB; Yang KH; Rao G; Rayner CR; Nie J; Pamulapati C; Marathe BM; Forrest A; Govorkova EA
PLoS One; 2015; 10(10):e0138069. PubMed ID: 26460484
[TBL] [Abstract][Full Text] [Related]
29. [Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1].
Leneva IA; Shuster AM
Vopr Virusol; 2006; 51(5):4-7. PubMed ID: 17087058
[TBL] [Abstract][Full Text] [Related]
30. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
31. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection.
Oxford JS; Lambkin R; Guralnik M; Rosenbloom RA; Petteruti MP; Digian K; LeFante C
Am J Ther; 2007; 14(5):462-8. PubMed ID: 17890936
[TBL] [Abstract][Full Text] [Related]
32. IgG antibodies mediate protective immunity of inactivated vaccine for highly pathogenic H5N1 influenza viruses in ferrets.
Shin JS; Kim HS; Cho SH; Seo SH
Viral Immunol; 2010 Jun; 23(3):321-7. PubMed ID: 20565295
[TBL] [Abstract][Full Text] [Related]
33. Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab')2.
Zhao Z; Fan C; Duan Y; Zhang L; Li M; Yang X; Li R; Yang P; Wang X
Int Immunopharmacol; 2014 Nov; 23(1):134-8. PubMed ID: 25192652
[TBL] [Abstract][Full Text] [Related]
34. Intranasal immunization of recombinant Lactococcus lactis induces protection against H5N1 virus in ferrets.
Lei H; Peng X; Ouyang J; Zhao D; Jiao H; Shu H; Ge X
Virus Res; 2015 Jan; 196():56-9. PubMed ID: 25445345
[TBL] [Abstract][Full Text] [Related]
35. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
[TBL] [Abstract][Full Text] [Related]
36. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.
Govorkova EA; Webby RJ; Humberd J; Seiler JP; Webster RG
J Infect Dis; 2006 Jul; 194(2):159-67. PubMed ID: 16779721
[TBL] [Abstract][Full Text] [Related]
37. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
Taylor WR; Thinh BN; Anh GT; Horby P; Wertheim H; Lindegardh N; de Jong MD; Stepniewska K; Hanh TT; Hien ND; Bien NM; Chau NQ; Fox A; Ngoc NM; Crusat M; Farrar JJ; White NJ; Ha NH; Lien TT; Trung NV; Day N; Binh NG
PLoS One; 2008; 3(10):e3410. PubMed ID: 18923671
[TBL] [Abstract][Full Text] [Related]
38. Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus.
Wang X; Zhao J; Tang S; Ye Z; Hewlett I
PLoS One; 2010 Aug; 5(8):e12099. PubMed ID: 20730085
[TBL] [Abstract][Full Text] [Related]
39. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
40. A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission.
Wu R; Li X; Leung HC; Cao Z; Qiu Z; Zhou Y; Zheng BJ; He Y
Antiviral Res; 2014 Jun; 106():13-23. PubMed ID: 24681124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
